Informatie:
Fout:
ID
34147
Beschrijving
A Combined GWAS and miRNA for the Identification of Bevacizumab Response Predictors in Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01598285
Link
https://clinicaltrials.gov/show/NCT01598285
Trefwoorden
Versies (1)
- 14-01-19 14-01-19 -
Houder van rechten
GSK group of companies
Geüploaded op
14 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Breast Cancer Invasive Nos NCT01598285
Eligibility Breast Cancer Invasive Nos NCT01598285
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer Invasive Nos NCT01598285
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
patients with breast cancer, at a disseminated stage
boolean
ID.2
Item
patients treated with bevacizumab in combination with weekly paclitaxel as first line chemotherapy and who have progressed
boolean
ID.3
Item
alive patients authorizing the extraction and analysis of their biological samples.
boolean
ID.4
Item
patients with a second neoplasia
boolean
ID.5
Item
deceased patients
boolean
ID.6
Item
patients who have not agreed to participate in the study
boolean
ID.7
Item
her2 positive patients
boolean
ID.8
Item
patients with cns metastases when first treated with bevacizumab in combination with paclitaxel
boolean
ID.9
Item
patients with local-regional recurrence only and
boolean
ID.10
Item
patients with status ned (resected metastases)
boolean